Literature DB >> 22653897

Effects of amitriptyline, fluoxetine, tranylcypromine and venlafaxine on rat vascular smooth muscle in vitro--the role of the endothelium.

S Ribback1, D Pavlovic, D Herbst, R Nedeljkov-Jancic, M Wendt, V Nedeljkov, S Bleich, H Frieling.   

Abstract

Hypotension is a frequent side effect of the antidepressant treatment. It is controversial whether this effect is attributable to interactions within the central nervous or the cardiovascular system. We examined often used antidepressants for their vasoactive properties in vitro in rat aortal rings with and without endothelium. The influence of pre-incubation with the antidepressants (0.5 μM) on adrenergic elicited smooth muscle contraction and the effects of cumulative concentrations (0.05 μM-500 μM) of the antidepressants on isometric tension were measured. In addition, conceivable modulation of the NO-cGMP, adrenergic and potassium channel pathways were examined. Amitriptyline and fluoxetine inhibited, whereas tranylcypromine enhanced adrenergic elicited responses of smooth muscle contraction. The antidepressants amitriptyline, fluoxetine and tranylcypromine showed, to a different extent, vasorelaxing properties in the preparations pre-contracted with phenylephrine 0.1 μM; the pEC50, (means and S.E.M.) in descending order of potency: amitriptyline 6.98 (0.13), fluoxetine 6.11 (0.05), tranylcypromine 5.33 (0.05) (n=8 each, preparations with endothelium); or after pre-contraction with KCl 20 mM: fluoxetine 6.00 (0.06), tranylcypromine 4.99 (0.30), amitriptyline, 4.89 (0.11), (n=7 each, preparations with endothelium). Venlafaxine did not relax the aortal rings and even lead to further contraction of the endothelium intact preparations. The observed effects were partially endothelium dependent via activation of the NO-cGMP pathway and some probably mediated through K+ channel activation. Amitriptyline, fluoxetine and tranylcypromine relax rat aorta in vitro. They partially delay vascular smooth muscle reactions to adrenergic agonists and can lead to sustained hypotension episodes despite administration of sympathomimetic drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22653897

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  6 in total

1.  Tricyclic antidepressant amitriptyline inhibits autophagic flux and prevents tube formation in vascular endothelial cells.

Authors:  Yinglu Guan; Xiang Li; Michihisa Umetani; Krishna M Boini; Pin-Lan Li; Yang Zhang
Journal:  Basic Clin Pharmacol Toxicol       Date:  2018-11-15       Impact factor: 4.080

2.  Investigation of effects of fluoxetine on the bronchial smooth muscles by the isolated organ bath system.

Authors:  Hajer Mohamed Hmmam; Muhsine Sinem Ethemoglu; Meltem Yalcin; Cihan Suleyman Erdogan; Bayram Yilmaz; Mehtap Kacar
Journal:  Biol Futur       Date:  2022-08-07

3.  Peripheral microvascular serotoninergic signaling is dysregulated in young adults with major depressive disorder.

Authors:  Jody L Greaney; Gabrielle A Dillon; Erika F H Saunders; Lacy M Alexander
Journal:  J Appl Physiol (1985)       Date:  2019-11-21

4.  Effects of in vitro Amitriptyline, Fluoxetine, Tranylcypromine and Venlafaxine on Saphenous Vein Grafts.

Authors:  Melek Akinci; Cetin Hakan Karadag; Serhat Huseyin; Cagatay Oltulu; Suat Canbaz; Ozgur Gunduz; Ruhan Deniz Topuz
Journal:  Braz J Cardiovasc Surg       Date:  2019-06-01

Review 5.  The Etiology and Molecular Mechanism Underlying Smooth Muscle Phenotype Switching in Intimal Hyperplasia of Vein Graft and the Regulatory Role of microRNAs.

Authors:  Dengshen Zhang; Yiran Cao; Daxing Liu; Jian Zhang; Yingqiang Guo
Journal:  Front Cardiovasc Med       Date:  2022-07-28

Review 6.  Off-Target Effects of Antidepressants on Vascular Function and Structure.

Authors:  Anna Dimoula; Dimitrios Fotellis; Evmorfia Aivalioti; Dimitrios Delialis; Alexia Polissidis; Raphael Patras; Nikolaos Kokras; Kimon Stamatelopoulos
Journal:  Biomedicines       Date:  2021-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.